Final efficacy results of neratinib in HER2-positive hormone receptor-positive early-stage breast cancer from the phase III ExteNET trial

Journal

Clinical Breast Cancer

Date Issued

2020-10

Author(s)

Chan, Arlene

Moy, Beverly

Mansi, Janine

Ejlertsen, Bent

Holmes, Frankie Ann

Chia, Stephen

Iwata, Hiroji

Gnant, Michael

Loibl, Sibylle

Barrios, Carlos H.

Somali, Isil

Martinez, Noelia

Alonso, Mirta Garcia

Link, John S.

Mayer, Ingrid A.

Cold, Søren

Murillo, Serafin Morales

Senecal, Francis

Inoue, Kenichi

Ruiz-Borrego, Manuel

Hui, Rina

Denduliri, Neelima

Patt, Debra

Rugo, Hope S.

Johnston, Stephen R.D.

Bryce, Richard

Zhang, Bo

Xu, Feng

Wong, Alvin

Martin, Miguel

DOI

10.1016/j.clbc.2020.09.014